|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Analysis of 16S-23S intergenic spacer regions and RNA operon copy number of Aeromonas culicicola MTCC 3249T 显示文摘 | Pidiyar V J Janqid K Patole M S | 2003 | DNA Sequence2003，14，3： | 1 |
| 2 | Sildenafil for 'blue babies'显示文摘 | Oliver J Webb D Patole S | 2002 | BMJ2002，325，： | 1 |
| 3 | Probioties for prevention of necrotising enterocolitis in preterm neonates with very low birthweight:a systematic review of randomised controlled trials 显示文摘 | Deshpande G Rao S Patole S | 2007 | Lancet2007，369，9573： | 1 |
| 4 | Early probiotics to prevent childhood metabolic syndrome: A systematic review显示文摘AIM: To conduct a systematic review of studies on early probiotic supplementation to prevent childhood metabolic syndrome(MS).METHODS: Using the Cochrane systematic review strategy we searched Pub Med, EMBASE, CENTRAL, CINAHL, and the conference proceedings of the Pediatric American Society meetings and trial registries in December 2014. Randomised controlled trials(RCTs) and non RCTs of probiotic supplementation to the mother and/or infant for a minimum duration of 4 wk were selected. Of these, studies that reported on MS or its components(obesity, raised blood pressure, hyperglycemia, dyslipidemia) in children between 2-19 years were to be eligible for inclusion in the review. Risk of bias(ROB) in selected RCTs and quality assessment of non-RCT studies were to be assessed by the Cochrane ROB assessment table and New Castle Ottawa scale.RESULTS: There were no studies on early probiotic administration for prevention of childhood MS(CMS). Follow up studies of two placebo controlled RCTs(n = 233) reported on the effects of early probiotics on one or more components of MS in children aged 2-19 years. Meta-analysis of those two studies could not be performed due to differences in the patient population, type of outcomes studied and the timing of their assessment. Assessment of childhood metabolic outcomes was not the primary objective of these studies. The first study that assessed the effects of prenatal and postnatal supplementation of Lactobacillus rhamnosus GG on body mass index till 10 years, did not report a significant benefit. In the second study, Lactobacillus paracasei 19 was supplemented to healthy term infants from 4-13 mo. No significant effect on body mass index, body composition or metabolic markers was detected. CONCLUSION: Current evidence on early probiotic administration to prevent CMS is inadequate. Gaps in knowledge need to be addressed before large RCTs can be planned. | Haribalakrishna Balasubramanian Sanjay Patole | 2015 | World Journal of Methodology2015，5，3： | 1 |
| 5 | Erythromycin as a prokinetic agent in preterm neonates: a systematic review 显示文摘 | Patole S Rao S Doherty D | 2005 | Arch Dis Child Fetal Neonatal Ed2005，90，4： | 1 |
| 6 | A facile approach to the fabrication of graphene/polystyrene nanocomposite by in situ microemulsion polymerization显示文摘 | Patole A S Patole S P Kang H | 2010 | Journal of Colloid and Interface Science2010，350，2： | 1 |
| 7 | Erythromycin as a prokinetic agent in pre- term neonates:a systematic review显示文摘 | Patole S Rao S Doherty D | 2005 | Arch Dis Child Fetal Neonatal Ed2005，90，4： | 1 |
| 8 | Antibiotic-impregnated cathe- ters for the prevention of CSF shunt infections: a systematic re- view and meta-analysis显示文摘 | Thomas R Lee S Patole S etal | 2012 | Br J Neurosurg2012，26，2： | 1 |
| 9 | Toll-Like Receptor-7 Modulates Immune Complex Glomerulonephritis显示文摘 | Rahul D Pawar Prashant S Patole Daniel Zecher | 2006 | J Am Soc Nephrol2006，17，： | 1 |
| 10 | Erythromycin for feed intolerance in preterm neonate:A randomised controlled trial显示文摘 | Almonte R Patole SK Kadalraja R | 1999 | Pediatr Res1999，45，2： | 1 |
| 11 | Probiotics for prevention of necrotisingenterocolitis in pretema neonateswith very low birthweight: a systematicreview of randomiscd controlled trials 显示文摘 | Deshpande G Rao S Patole S | 2007 | Lancet2007，369，9573： | 1 |
| 12 | Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates显示文摘 | Patole SK Almonte R Kadalraja R | 2000 | Int J Clin Pract2000，54，3： | 1 |
| 13 | Massive fetomaternal Hemorrhage with persistent pulmonary hypertension in a neonate显示文摘 | Parveen V Patole SK Whitehall JS | 2002 | Indian Pediatric2002，39，4： | 1 |
| 14 | Neonatal outcome of gastroschisis and exomphalos: a 10-year review 显示文摘 | Kitchananan S Patole SK Muller R | 2000 | J PaediatrChild Health2000，36，： | 1 |
| 15 | Permissive hypercapnia in neonates :The case of the good the bad ,and the ugly显示文摘 | Varughese M Patole S Shama A | 2002 | Pediatr Pulmonol2002，33，1： | 1 |
| 16 | Neurodevelopmen- tal outcomes of very low-birth-weight infants with neerotizing enterocolitis: a systematic review of observational studies 显示文摘 | Schulzke SM Deshpande GC Patole SK | 2007 | ArehPediatrAdoleseMed2007，161，6： | 1 |
| 17 | Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates显示文摘 | Deshpande G Rao S Patole S J | 2010 | Pediatr2010，125，5： | 1 |
| 18 | Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates显示文摘 | Deshpande G Rao S Patole S | 2010 | Pediatrics2010，125，： | 1 |
| 19 | Reversal of glucose intolerance by pioglitazone in high fat tiler-fed rats显示文摘 | Srinivasan K Patole PS Kaul CL | 2004 | Methods Find Exp Clin Pharmacol2004，26，5： | 1 |
| 20 | Erythromycin as a prokinetic agent in preterm neonates:a systematic review显示文摘 | Patole S Rao S Doherty D | | 0，，04： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员